WO2007048100A3 - Angio-inhibitory peptides derived from human timp-2 - Google Patents
Angio-inhibitory peptides derived from human timp-2 Download PDFInfo
- Publication number
- WO2007048100A3 WO2007048100A3 PCT/US2006/060059 US2006060059W WO2007048100A3 WO 2007048100 A3 WO2007048100 A3 WO 2007048100A3 US 2006060059 W US2006060059 W US 2006060059W WO 2007048100 A3 WO2007048100 A3 WO 2007048100A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- angio
- peptides derived
- inhibitory peptides
- human timp
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention provides proteins and polypeptides with anti-angiogenic activity. The proteins may be prepared by recombinant or other synthetic means and may be formulated in compositions as needed to facilitate their use. The invention further provides methods of inhibiting or reducing angiogenesis as well as the treatment of angiogenesis mediated diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72814605P | 2005-10-18 | 2005-10-18 | |
US60/728,146 | 2005-10-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007048100A2 WO2007048100A2 (en) | 2007-04-26 |
WO2007048100A3 true WO2007048100A3 (en) | 2008-02-07 |
Family
ID=37963410
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/060059 WO2007048100A2 (en) | 2005-10-18 | 2006-10-18 | Angio-inhibitory peptides derived from human timp-2 |
PCT/US2006/060061 WO2007048102A2 (en) | 2005-10-18 | 2006-10-18 | Angio-inhibitory peptides derived from human timp-2 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/060061 WO2007048102A2 (en) | 2005-10-18 | 2006-10-18 | Angio-inhibitory peptides derived from human timp-2 |
Country Status (1)
Country | Link |
---|---|
WO (2) | WO2007048100A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2016001573A (en) * | 2013-08-07 | 2016-09-07 | Astute Medical Inc | Assays for timp2 having improved performance in biological samples. |
US11718682B2 (en) | 2017-04-05 | 2023-08-08 | Astute Medical, Inc. | Assays for TIMP2 having improved performance in biological samples |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990011287A1 (en) * | 1989-03-21 | 1990-10-04 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Matrix metalloproteinase inhibitor peptides |
WO2003057884A1 (en) * | 2002-01-08 | 2003-07-17 | Leadbio Inc. | Human serum albumin-timp2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-timp2 fusion protein |
WO2004060275A2 (en) * | 2002-12-19 | 2004-07-22 | Kimberly-Clark Worldwide, Inc. | Wound care compositions |
-
2006
- 2006-10-18 WO PCT/US2006/060059 patent/WO2007048100A2/en active Application Filing
- 2006-10-18 WO PCT/US2006/060061 patent/WO2007048102A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990011287A1 (en) * | 1989-03-21 | 1990-10-04 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Matrix metalloproteinase inhibitor peptides |
WO2003057884A1 (en) * | 2002-01-08 | 2003-07-17 | Leadbio Inc. | Human serum albumin-timp2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-timp2 fusion protein |
WO2004060275A2 (en) * | 2002-12-19 | 2004-07-22 | Kimberly-Clark Worldwide, Inc. | Wound care compositions |
Non-Patent Citations (2)
Title |
---|
FERNANDEZ CECILIA A ET AL: "Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2). Loop 6 is a novel angiogenesis inhibitor.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 278, no. 42, 17 October 2003 (2003-10-17), pages 40989 - 40995, XP002435349, ISSN: 0021-9258 * |
SEO D-W ET AL: "TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 114, no. 2, 25 July 2003 (2003-07-25), pages 171 - 180, XP002313229, ISSN: 0092-8674 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007048100A2 (en) | 2007-04-26 |
WO2007048102A2 (en) | 2007-04-26 |
WO2007048102A3 (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008101985A3 (en) | Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization | |
WO2007044534A3 (en) | Vegf analogs and methods of use | |
WO2011123830A3 (en) | Alpha 1-antitrypsin compositions and methods of making and using same | |
CR20140465A (en) | PROTEINS OF UNION TO INTERLEUQUINA-13 | |
MX354555B (en) | Growth hormone polypeptides and methods of making and using same. | |
TN2012000372A1 (en) | Fibronectin based scaffold domain proteins that bind il-23 | |
WO2012058393A3 (en) | Dkk1 antibodies and methods of use | |
SI2190473T1 (en) | Peptide with reduced dimer formation | |
EP2470670A4 (en) | Coagulation factor vii compositions and methods of making and using same | |
WO2006113681A3 (en) | Plant-derived elastin binding protein ligands and methods of using the same | |
MX2010002716A (en) | Neuroendocrine factors for treatment of degenerative diseases. | |
WO2010130830A3 (en) | Anti-sclerostin vhh and their use for treating bone diseases | |
DE602008002693D1 (en) | VACCINE PEPTIDE COMBINATIONS AGAINST CATERING ALLERGY | |
WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
ATE457736T1 (en) | COMPOSITION OF A PULMONARY SURFACTANT AND A PEPTIDE DERIVED FROM TNF | |
WO2005123916A3 (en) | Glycosylation-disrupted factor vii variants | |
WO2010021874A3 (en) | Engineered anti-il-13 antibodies, compositions, methods and uses | |
WO2010146578A3 (en) | Peptide therapy for increasing platelet levels | |
HRP20140888T1 (en) | Human monoclonal antibodies against human il-4 | |
WO2010014830A3 (en) | Peptide therapeutics that bind vegf and methods of use thereof | |
MX2010002769A (en) | Recombinant preparation of selected bromelain fractions. | |
WO2008040190A8 (en) | Small peptides for anti-angiogenesis and use thereof | |
WO2010142551A8 (en) | Amino acid sequences directed against receptors to cytokines belonging to the il-17 family | |
WO2011115456A3 (en) | Tnf-α and tweak dual antagonist for the prophylaxis and treatment of autoimmune diseases | |
EP2123680A4 (en) | Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06839464 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06839464 Country of ref document: EP Kind code of ref document: A2 |